Isomorphic Labs

Isomorphic Labs applies advanced artificial intelligence to redesign how new medicines are discovered, using predictive and generative models to explore biological targets and chemical possibilities more efficiently. Building on the scientific foundations of AlphaFold, its unified drug-design engine supports research across therapeutic areas and multiple treatment types.

NewsHeat chart

  • Week
  • Month
  • Year
  • Media news
  • Corp news
Click to unlock the chart

The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice

Company Valuation

  • Valuation
  • Share Price
  • Cumulative Funding

The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.

Funding Round
Funding Amount
Post-Money Valuation
Share Price
Series B12 May, 2026
***
***
***
Series A31 Mar, 2025
***
***
***
Seed10 Apr, 2022
***
***
***

*** - To view the data, please log into your account or create a new one.

News related to Isomorphic Labs1

Filter by
Sort by
Isomorphic Labs
May 12, 2026 •Show on chart

Isomorphic Labs Raises $2.1 Billion in Series B Funding

The round was led by Thrive Capital, with participation from Alphabet, GV, MGX, Temasek, CapitalG, and the UK Sovereign AI Fund. ...

https://www.finsmes.com/2026/05/isomorphic-labs-raises-2-1-billion-in-series-b-funding.html

Investors3

Thrive CapitalThrive Capital
Temasek HoldingsTemasek Holdings
AlphabetAlphabet